Highly Selective SYK Inhibitor, GSK143, Abrogates Survival Signals in Chronic Lymphocytic Leukaemia
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14884
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 2, 2017
Authors
Publisher
Wiley